Complete genome sequences have provided a plethora of potential drug targets. But the hard task of finding their weak spots is just beginning, as Caitlin Smith finds out.
Login or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Author information
Author notes
Caitlin Smith is a science writer based in Portland, Oregon.
- Caitlin Smith
Rights and permissions
About this article
Cite this article
Smith, C. A question of biology. Nature 428, 225 (2004). https://doi.org/10.1038/428225a
Issue Date:
DOI: https://doi.org/10.1038/428225a
This article is cited by
-
GOAL: the comprehensive gene ontology analysis layer
Science China Information Sciences (2016)
-
Two-stage flux balance analysis of metabolic networks for drug target identification
BMC Systems Biology (2011)
-
Material basis for inhibition of Dragon’s Blood on evoked discharges of wide dynamic range neurons in spinal dorsal horn of rats
Science in China Series C: Life Sciences (2008)